MultiHance (BRACCO DIAGNOSTICS INC)
Welcome to the PulseAid listing for the MultiHance drug offered from BRACCO DIAGNOSTICS INC. This Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | BRACCO DIAGNOSTICS INC |
| NON-PROPRIETARY NAME: | gadobenate dimeglumine |
| SUBSTANCE NAME: | GADOBENATE DIMEGLUMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-11-23 |
| END MARKETING DATE: | 0000-00-00 |
MultiHance HUMAN PRESCRIPTION DRUG Details:
| Item Description | MultiHance from BRACCO DIAGNOSTICS INC |
| LABELER NAME: | BRACCO DIAGNOSTICS INC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 529(mg/mL) |
| START MARKETING DATE: | 2004-11-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0270-5164_731a17a7-aa4d-5d96-623c-a3fd02f1b6a0 |
| PRODUCT NDC: | 0270-5164 |
| APPLICATION NUMBER: | NDA021357 |
Other GADOBENATE DIMEGLUMINE Pharmaceutical Manufacturers / Labelers:
